{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:49:40Z","timestamp":1761630580406},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.rce.2010.05.026","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T22:08:32Z","timestamp":1299535712000},"page":"92-97","source":"Crossref","is-referenced-by-count":5,"title":["Interfer\u00f3n alfa y virus hepatitis C: la piel importa"],"prefix":"10.1016","volume":"211","author":[{"given":"U.","family":"Florist\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Feltes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ram\u00edrez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Herranz-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2010.05.026_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cgh.2006.06.010","article-title":"Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy","volume":"5","author":"Berk","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","article-title":"Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment","volume":"19","author":"Magrin","year":"1994","journal-title":"Hepatology."},{"key":"10.1016\/j.rce.2010.05.026_bib0015","first-page":"47","article-title":"Neoplastic transformation of oral lichen: case report and review of the literature","volume":"26","author":"Abbate","year":"2006","journal-title":"Acta Otorhinolaryngol Ital."},{"key":"10.1016\/j.rce.2010.05.026_bib0020","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2004.06257.x","article-title":"Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review","volume":"151","author":"Lodi","year":"2004","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1468-3083.2008.02676.x","article-title":"Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area","volume":"22","author":"Maticic","year":"2008","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.rce.2010.05.026_bib0030","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-4632.2008.03832.x","article-title":"Lack of evidence for hepatitis C virus infection in association with lichen planus","volume":"47","author":"Stojanovic","year":"2008","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0035","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archdermatol.2009.200","article-title":"Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis","volume":"145","author":"Shengyuan","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0040","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1111\/j.1365-2230.2008.03130.x","article-title":"Hepatitis C viral load decreases after cyclosporin treatment for erosive lichen planus","volume":"34","author":"Franchi","year":"2009","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clindermatol.2009.03.004","article-title":"etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies","volume":"28","author":"Farhi","year":"2010","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000247552","article-title":"Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy","volume":"184","author":"Doutre","year":"1992","journal-title":"Dermatology."},{"key":"10.1016\/j.rce.2010.05.026_bib0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/MEG.0b013e3282f1cc5d","article-title":"Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin","volume":"20","author":"Grossmann","year":"2008","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0190-9622(95)90427-1","article-title":"Successful treatment of generalized lichen planus with recombinant interferon alfa-2b","volume":"33","author":"Hildebrand","year":"1995","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/000155599750010418","article-title":"Lichen planus induced by interferon-alpha-2B therapy in a patient with cutaneous malignant melanoma","volume":"79","author":"Herrera Saval","year":"1999","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.rce.2010.05.026_bib0070","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/rheumatology\/kem132","article-title":"Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation","volume":"46","author":"Saadoun","year":"2007","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.rce.2010.05.026_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2007.085910","article-title":"The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders","volume":"68","author":"Landau","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rce.2010.05.026_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0085","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10620-009-0902-5","article-title":"Regression of B-cell lymphoma of the liver with hepatitis c virus infection after treatment with pegylated interferon-alpha and ribavirin","volume":"55","author":"Oda","year":"2010","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rce.2010.05.026_bib0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.rce.2010.05.026_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rce.2010.05.026_bib0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J Hepatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2230.2001.00825.x","article-title":"The management of porphyria cutanea tarda","volume":"26","author":"Sarkany","year":"2001","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520310000672a","article-title":"Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C","volume":"38","author":"Fern\u00e1ndez","year":"2003","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.rce.2010.05.026_bib0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0168-8278(95)80438-2","article-title":"Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda","volume":"22","author":"Takikawa","year":"1995","journal-title":"J Hepatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/PL00009978","article-title":"Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels","volume":"35","author":"Furuta","year":"2000","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.rce.2010.05.026_bib0125","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.3748\/wjg.14.5913","article-title":"Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C","volume":"14","author":"Azim","year":"2008","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rce.2010.05.026_bib0130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1023\/A:1026681218915","article-title":"Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C","volume":"44","author":"Rich","year":"1999","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.rce.2010.05.026_bib0135","first-page":"35","article-title":"Cutaneous necrosis complicating the injection of pegylated interferon -2b in a patient with chronic hepatitis C","volume":"16","author":"Rosina","year":"2008","journal-title":"Acta Dermatovenerol Croat."},{"key":"10.1016\/j.rce.2010.05.026_bib0140","doi-asserted-by":"crossref","unstructured":"Lubbe J. Adverse skin reactions associated with hepatitis C treatment: comment. J Dermatol. 2008; 35:250; author reply 251.","DOI":"10.1111\/j.1346-8138.2008.00458.x"},{"key":"10.1016\/j.rce.2010.05.026_bib0145","first-page":"27","article-title":"Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. A case report","volume":"43","author":"Honsova","year":"2007","journal-title":"Cesk Patol."},{"key":"10.1016\/j.rce.2010.05.026_bib0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2008.10.006","article-title":"Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin","volume":"60","author":"Lin","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2340\/00015555-0039","article-title":"Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy","volume":"86","author":"Bettoli","year":"2006","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.rce.2010.05.026_bib0160","first-page":"570","article-title":"Multiple fixed drug eruption with interferon\/ribavirin combination therapy for hepatitis C virus infection","volume":"2","author":"Sidhu-Malik","year":"2003","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0165","first-page":"343","article-title":"Xerostomia and lichenoid reaction in a hepatitis C patient treated with interferon-alpha: a case report","volume":"39","author":"Ojha","year":"2008","journal-title":"Quintessence Int."},{"key":"10.1016\/j.rce.2010.05.026_bib0170","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-4632.2008.03724.x","article-title":"Drug-induced Sweet's syndrome secondary to hepatitis C antiviral therapy","volume":"47","author":"Gheorghe","year":"2008","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.rce.2010.05.026_bib0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1752-1947-1-86","article-title":"Extensive psoriasis induced by pegylated interferon: a case report","volume":"1","author":"Citro","year":"2007","journal-title":"J Med Case Reports."},{"key":"10.1016\/j.rce.2010.05.026_bib0180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0961203309353172","article-title":"Systemic lupus erythematosus and Sjogren syndrome induced in a case by interferon-{alpha} used for the treatment of hepatitis C","volume":"19","author":"Onishi","year":"2010","journal-title":"Lupus."},{"key":"10.1016\/j.rce.2010.05.026_bib0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0046-8177(03)00193-X","article-title":"The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases","volume":"34","author":"Crowson","year":"2003","journal-title":"Hum Pathol."}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256510005175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256510005175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T02:21:03Z","timestamp":1637374863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256510005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0014256510005175"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2010.05.026","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}